Dianon takes ThinPrep to 50,000 US physicians:
This article was originally published in Clinica
Dianon Systems has reached an agreement with Cytyc to take its ThinPrep cervical screening smear test in preference to the standard Pap smear. Dianon will use its salesforce - claimed to be the largest in the US anatomic pathology market - to sell ThinPrep as its primary enhanced Pap testing product to more than 50,000 physicians, as well as to payor groups.
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.